Web Analytics Made Easy - StatCounter

Intermediate Acting Insulin Tenders

Get complete information related to latest Intermediate Acting Insulin Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Intermediate Acting Insulin Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Intermediate Acting Insulin Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

Central Government/Public Sector

CTN :45682641 Due date: 06 Jul, 202606 Jul, 2026 NA
Tender For supply of ami no.12.25/2026-27 insulin human inj 30/70 vial 100 unit per ml in 10ml rdna origin (intermediate acting insulin)[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

State Government

CTN :45430932 Due date: 02 Jul, 202602 Jul, 2026 12.81 Crore
Tender For corrigendum : online tender for the rate contract for the supply of medicines to various hospitals of government of haryana for a period of two years for group a medicines - multivitamin injection 10 ml vial, potassium chloride (solution) injectable 15% (150mg/ml), 10 ml amp., methyl ergometrine injection 200 mcg in 1 ml ampoule, acyclovir tablet 400 mg, dobutamine injection 250mg/5ml, water for injection 5ml ampoule, chlorpheniramine tablet 4 mg, calcium gluconate injection 100 mg/ml, 10 ml amp, co-trimoxazole [sulphamethoxazole (a) + trimethoprim (b)] oral liquid 200 mg (a) + 40 mg (b)/5 ml, tobramycin opthalmic solution 0.3% w/v, 5ml, amphotericin b powder for injection 50 mg vial, streptokinase injection powder 1500000 iu, hydroxypropyl methylcellulose injection 2%, 3 ml pfs (glass syringe), risperidone injection long acting 25 mg, olanzapine injection 405 mg, olanzapine injection 10 mg, halothane inhalation 250 ml bottle, morphine tablet 20 mg, pralidoxime (pam) injection 1 gm vial, lorazepam injection 4mg, 2ml, phenobarbitone injection 200 mg/ ml, gentamycin injection 40 mg/ ml, 2 ml ampoule, norfloxacin tablet 400 mg, heparin injection, 1000 iu/ml, 5 ml vial, diltiazem injection 5 mg/ml , amiodarone injection 150 mg/ 3 ml, acetylsalicylic acid tablet 150 mg, intermediate-acting insulin (nph) injection 40 iu/ml in 10 ml vial, insulin glargine 100 units/ml, succinyl choline injection 50mg/ml, 10ml vial, neostigmine injection 500 mcg/ ml, 5 ml ampoule, vecuronium injection 4 mg dry powder / ampoule, hyaluronidase injection 1500 iu/ml, ciprofloxacin (0.3%) + dexametasone (0.1%) ear drops, 5ml, betamethasone injection 4mg/ml, fuji x-ray films (1x100) 14"x17"

Central Government/Public Sector

CTN :45404253 Due date: 18 Jun, 202618 Jun, 2026 NA
Tender For corrigendum : supply of ami no.12.25/2026-27 insulin human inj 30/70 vial 100 unit per ml in 10ml rdna origin (intermediate acting insulin)[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

Central Government/Public Sector

CTN :45438105 Due date: 19 Jun, 202619 Jun, 2026 NA
Tender For corrigendum : supply of ami no.12.09/2026-27 insulin biphasic aspart inj (insulin aspart and insulin aspart protamine 30/70) catridge 100iu per ml in 3ml each (intermediate acting insulin)[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

Central Government/Public Sector

CTN :45556892 Due date: 18 Jun, 202618 Jun, 2026 NA
Tender For supply of ami no.12.25/2026-27 insulin human inj 30/70 vial 100 unit per ml in 10ml rdna origin (intermediate acting insulin)[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

Central Government/Public Sector

CTN :45556921 Due date: 19 Jun, 202619 Jun, 2026 NA
Tender For supply of ami no.12.09/2026-27 insulin biphasic aspart inj (insulin aspart and insulin aspart protamine 30/70) catridge 100iu per ml in 3ml each (intermediate acting insulin)[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

CTN :45486008 Due date: 24 Jun, 202624 Jun, 2026 NA
Tender For purchase of lab equipments for department of chemistry - oxygen (medicinal gas) inhalation, halothane inhalation 250 ml bottle, ketamine (as hydrochloride) injection 50 mg /ml,10 ml vial, nitrous oxide inhalation, thiopentone injection powder 0.5 g, morphine injection 10 mg/ml, 1 ml ampoule, morphine tablet 20 mg, tramadol injection 50 mg/ml, 2 ml ampoule, tramadol hydrochloride capsule 100 mg, sulfasalazine tablet 500 mg, methotrexate tablet 2.5 mg, chlorpheniramine tablet 4 mg, cyproheptadine tablet 4 mg, naloxone injection 400 mcg/ml, 1ml ampoule, carbamazepine tablet 200 mg, carbamazepine tablet 400 mg, carbamazepine oral solution 100mg/5ml, 30 ml bottle, phenytoin oral solution 25 mg/ml, 100 ml glass bottle, sodium valproate injection 100 mg/ml, sodium valproate suspension 200 mg/5 ml, 100 ml, clobazam capsule 10 mg, toperamate tablet 50 mg, levamasole tablet 50 mg, levamasole tablet 150 mg, immipenum injection 500 mg, elemental iron 60 mg +folic acid 500 mcg, sugar coated and red color tablet, hydroxycobalamin injection 1 mg/ ml, warfarin (sodium) tablet 2 mg, glyceryl trinitrate (sublingual) tablet 500 micrograms, isosorbide mononitrate tablet 30 mg (sr), isosorbide dinitrate tablet (sublingual) 5 mg, methyldopa tablet 250 mg, methyldopa tablet 500 mg, nifedipine capsule(sublingual) 5 mg, nifedipine tablet ip sr/er 10 mg, clinidipine tablet 20 mg, hydrochlorthiazide tablet 12.5 mg, chlorthalidone tablet 6.25 mg, nebivalol tablet 5 mg, clotrimazole pessaries 200 mg, framycetin cream 1%, 30 gm tube, gentian violet (methylrosanilinium chloride paint preparation aqueous solution 0.5%w/v), 50 ml dark bottle, podophylline resin topical solution 25% , 10 ml bottle, coal tar solution 5% w/v, 100 ml bottle, salicylic acid ointment 6%, 15 gm tube, white petrolatum jelly 100 %, 50 gm jar, cotrimazole 1 % + betamethasone 0.0025% lotion 15 ml, kojic acid cream 2 %, tacrolimus ointment 0.1%, halobetasol propionate + salicylic acid 3% ointment, minoxidil solution 5%, isotretinoin capsule 20 mg, methoxsalen tablet 10 mg, triamcinolone injection 20 mg/ ml, hydrogen peroxide solution 6%, 400 ml bottle, cetrimide solution 20% conc. for dilution, 500 ml plastic bottle, chlorhexidine solution 5% conc. for dilution, 500 ml, potassium permanganate crystal for solution 100 gm, alkalizer mb6 500ml (potassium citrate magnisum citrate syrup & vit b6), bethanecholchloride tablet 25 mg, darifenacin tablet 7.5 mg, silodosin tablet 8.0 mg, mirabegron tablet 50 mg, pyridium tablet 200 mg, dried aluminium hydroxide gel + magnesium hydroxide + simethicone oral suspension 250 mg+ 250 mg+ 50 mg/ 5 ml, 180 ml bottle, aluminium hydroxide 240 mg + magnesium hydroxide 100mg+ simethicone 25 mg + magnesium carbonate 60 mg chewable tablet, metoclopramide tablet 10 mg, promethazine (hydrochloride) elixir or syrup 5 mg/5 ml, 60 ml bottle, prochlorperazine mouth dissolving tablet flavored base 5mg, ispaghula granules/ husk/ powder 100 gm, octreotide injection 100 mcg/ml, single dose 1 ml vial, saccharomyces boulardii 5 cfu sachets, erythropoietin injection 40000 units/ml, single dose 1 ml vial, intermediate-acting insulin (nph) injection 40 iu/ml in 10 ml vial, biphasic isophane injection 40 i.u/ml, (30/70), 10 ml vial, clomifene citrate tablet 50 mg, conjugated estrogen tablet 0.625 mg, carbimazole tablet 5 mg, ethinyestradiol tablet 5 mcg, estrogens cream 0.625 mg, succinyl choline injection 50mg/ml, 10ml vial, ciprofloxacin opthalmic ointment 0.3 % 5 gm tube, acylovir eye oint 5%,5 gm, povidone iodine 5% eye drops, prednisolone sodium phosphate eye drops 1%, 5 ml, atropine drops 1%, atropine eye ointment 1%, cyclopentolate eye drops 1% w/v, hydroxypropyl methylcellulose injection 2% , 3 ml pfs (glass syringe), sodium chloride topical eye drops 6% w/w, 5 ml, ichthoimol glycerine solution 10 ml vial, raybiotic-ac ear drop (beclomethasone +chloramphenical+clotimazole+lignocaine), methyl ergometrine tablet 125 mcg, misoprostol tablet 25 mg, isoxsuprine tablet 10

CTN :45486252 Due date: 22 Jun, 202622 Jun, 2026 NA
Tender For supply of lab items and other items - oxygen (medicinal gas) inhalation, halothane inhalation 250 ml bottle, ketamine (as hydrochloride) injection 50 mg /ml,10 ml vial, nitrous oxide inhalation, thiopentone injection powder 0.5 g, morphine injection 10 mg/ml, 1 ml ampoule, morphine tablet 20 mg, tramadol injection 50 mg/ml, 2 ml ampoule, tramadol hydrochloride capsule 100 mg, sulfasalazine tablet 500 mg, methotrexate tablet 2.5 mg, chlorpheniramine tablet 4 mg, cyproheptadine tablet 4 mg, naloxone injection 400 mcg/ml, 1ml ampoule, carbamazepine tablet 200 mg, carbamazepine tablet 400 mg, carbamazepine oral solution 100mg/5ml, 30 ml bottle, phenytoin oral solution 25 mg/ml, 100 ml glass bottle, sodium valproate injection 100 mg/ml, sodium valproate suspension 200 mg/5 ml, 100 ml, clobazam capsule 10 mg, toperamate tablet 50 mg, levamasole tablet 50 mg, levamasole tablet 150 mg, immipenum injection 500 mg, elemental iron 60 mg +folic acid 500 mcg, sugar coated and red color tablet, hydroxycobalamin injection 1 mg/ ml, warfarin (sodium) tablet 2 mg, glyceryl trinitrate (sublingual) tablet 500 micrograms, isosorbide mononitrate tablet 30 mg (sr), isosorbide dinitrate tablet (sublingual) 5 mg, methyldopa tablet 250 mg, methyldopa tablet 500 mg, nifedipine capsule(sublingual) 5 mg, nifedipine tablet ip sr/er 10 mg, clinidipine tablet 20 mg, hydrochlorthiazide tablet 12.5 mg, chlorthalidone tablet 6.25 mg, nebivalol tablet 5 mg, clotrimazole pessaries 200 mg, framycetin cream 1%, 30 gm tube, gentian violet (methylrosanilinium chloride paint preparation aqueous solution 0.5%w/v), 50 ml dark bottle, podophylline resin topical solution 25% , 10 ml bottle, coal tar solution 5% w/v, 100 ml bottle, salicylic acid ointment 6%, 15 gm tube, white petrolatum jelly 100 %, 50 gm jar, cotrimazole 1 % + betamethasone 0.0025% lotion 15 ml, kojic acid cream 2 %, tacrolimus ointment 0.1%, halobetasol propionate + salicylic acid 3% ointment, minoxidil solution 5%, isotretinoin capsule 20 mg, methoxsalen tablet 10 mg, triamcinolone injection 20 mg/ ml, hydrogen peroxide solution 6%, 400 ml bottle, cetrimide solution 20% conc. for dilution, 500 ml plastic bottle, chlorhexidine solution 5% conc. for dilution, 500 ml, potassium permanganate crystal for solution 100 gm, alkalizer mb6 500ml (potassium citrate magnisum citrate syrup & vit b6), bethanecholchloride tablet 25 mg, darifenacin tablet 7.5 mg, silodosin tablet 8.0 mg, mirabegron tablet 50 mg, pyridium tablet 200 mg, dried aluminium hydroxide gel + magnesium hydroxide + simethicone oral suspension 250 mg+ 250 mg+ 50 mg/ 5 ml, 180 ml bottle, aluminium hydroxide 240 mg + magnesium hydroxide 100mg+ simethicone 25 mg + magnesium carbonate 60 mg chewable tablet, metoclopramide tablet 10 mg, promethazine (hydrochloride) elixir or syrup 5 mg/5 ml, 60 ml bottle, prochlorperazine mouth dissolving tablet flavored base 5mg, ispaghula granules/ husk/ powder 100 gm, octreotide injection 100 mcg/ml, single dose 1 ml vial, saccharomyces boulardii 5 cfu sachets, erythropoietin injection 40000 units/ml, single dose 1 ml vial, intermediate-acting insulin (nph) injection 40 iu/ml in 10 ml vial, biphasic isophane injection 40 i.u/ml, (30/70), 10 ml vial, clomifene citrate tablet 50 mg, conjugated estrogen tablet 0.625 mg, carbimazole tablet 5 mg, ethinyestradiol tablet 5 mcg, estrogens cream 0.625 mg, succinyl choline injection 50mg/ml, 10ml vial, ciprofloxacin opthalmic ointment 0.3 % 5 gm tube, acylovir eye oint 5%,5 gm, povidone iodine 5% eye drops, prednisolone sodium phosphate eye drops 1%, 5 ml, atropine drops 1%, atropine eye ointment 1%, cyclopentolate eye drops 1% w/v, hydroxypropyl methylcellulose injection 2% , 3 ml pfs (glass syringe), sodium chloride topical eye drops 6% w/w, 5 ml, ichthoimol glycerine solution 10 ml vial, raybiotic-ac ear drop (beclomethasone +chloramphenical+clotimazole+lignocaine), methyl ergometrine tablet 125 mcg, misoprostol tablet 25 mg, isoxsuprine tablet 10 mg, isoxsuprine in

Central Government/Public Sector

CTN :45415921 Due date: 30 Jun, 202630 Jun, 2026 NA
Tender For e-tender for procurement of drug items under table-a, for two years from the date of aoc. - amoxicillin trihydrate dispersible tabs. i.p 125mg, amoxycillin 250 mg + cloxacillin 250mg capsule., atropine sulphate inj. i.p. 0.6 mg/ml-1ml amp., azacitidine inj 100 mg /vial, azathioprine 50 mg tab., benzyl benzoate application i.p 25% w/w-500 ml bot., bimatoprost eye drop 0.03%, bupivacaine 0.5% inj - 20ml vial, cabergoline tab 0.5mg, caffeine citrate 1 ml inj per vial/amp, carmustine inj. 100mg/vial, cefotaxime sodium inj. i.p. 125 mg.vial., ceftazidime inj. 1gm./vial, cetuximab inj. 100mg( 5mg/ml) / - 20ml vial, cetuximab inj. 500 mg (5mg/ml)/100ml vial, cilostazol tab ip 50 mg, clopidogrel 75mg tab., daclatasvir 60 mg tab., decitabine inj 50 mg, deferasirox 250mg dispersable tab., desflurence inhalation agent 240 ml, dexamethasone 4 mg tab., dexamethasone tab. i.p. 0.5 mg, diclofenac sod. 50 mg tab., diclofenac sodium injection i.p. 25mg/ml- 3ml amps, digoxin tablet i.p. 0.25 mg, dorzolamide hydrochloride 2.0% eye drop in 5ml, fexofenadine tab 120 mg, fibrin sealent with fast & slow setting of thrombin 1ml, fludarabine inj. - 50mg / 5ml, flurourocil inj. i.p. 250mg. in 5ml. amp., fluticasone nasal spray ip 50 mcg (in maximum of 120 mdi pack), furosemide inj. i.p 20mg/2ml. ampoule, halazone tablet for solution u.s.p. 4mg, human hepatitis b immunoglobulin inj. 200 iu volume in 0.5 ml or 1 ml vial/pfs, ibrutinib 140 mg cap., infliximab inj. 100mg/vial, isosorbide-5-mononitrate 20 mg, isosorbide-dinitrate tab i.p. 5mg., ivermectin 6mg tab., leuprolide depot inj. 22.5 mg/vial, levetiracetam inj. 100 mg /ml in 5ml amps, levofloxacin 500 mg tab., levosalbutamol 1.25 mg + ipratropium bromide 500mcg respules, levosalbutamol oral suspension 1mg/5ml, linezolid infusion 600 mg / 300ml, linezolid syrup 100mg / 5ml, melphalan hcl inj. 50 mg (powder), methotrexate tab 15 mg, naproxen 250mg tab., neostigmine methylsulphate inj.i.p. 0.5mg/ ml - 1ml ampoule, nicorandil tabs 5mg, ondansetron inj. 2mg/ ml in 2ml amp., penicillamine 250 mg. cap., plerixafor inj 24mg/1.2ml per vial, polymixin b sulfate inj. 5,00,000 units/vial, pomalidomide 2mg tab / cap, prednisolone tab.20mg., pyrazinamide tab. i.p. 500mg, pyridostigmine tab 30 mg, risperidone tab. 2 mg, sacubitril + valsartan tab. 50mg, sodium chloride inj 0.45% in polypropelene bottle in ffs technology, sodium fusidate cream / ointment 2%, solifenacin 5mg tab., succinylated polygelline, sulfasalazine tab 500 mg, teicoplanin inj. 200 mg /vial, tetanus toxoid inj. (absorbed) 0.5ml amp. single dose, thiamine 100 mg. inj. per 2ml ampule, tinidazole tab ip 500 mg, tropicamide 0.8% with phenylephrine hydrochloride 5% eye drop, valethamate bromide inj 8 mg/ml in 1ml amp., vecuronium bromide inj. 2mg /ml 2ml vial, important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f

Central Government/Public Sector

CTN :45227724 Due date: 27 May, 202627 May, 2026 NA
Tender For supply of ami no.12.14/2026-27 insulin biphasic lispro inj (insulin lispro and insulin lispro protamine 25/75) pen of 100iu per ml (intermediate acting insulin)[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
 Loading, Please wait...

Connect us via What's Up